IBC Minutes

Saint John’s Cancer Institute maintains public access to approved Institutional Biosafety Committee meeting minutes in accordance with NIH transparency expectations for research involving recombinant or synthetic nucleic acid molecules.

The Institute uses the WCG Institutional Biosafety Committee (IBC) Services for applicable research oversight. Approved and appropriately redacted meeting minutes are posted below by meeting date and study reference.

Institutional Biosafety Committee Meeting Minutes

NIH expects approved minutes from IBC meetings occurring on or after June 1, 2025 to be made publicly available after approval and appropriate redaction. Minutes are listed below in reverse chronological order.

2026 Meeting Minutes

2025 Meeting Minutes

Additional IBC Records

The following records relate to IBC reviews that occurred before June 1, 2025 and are provided here for transparency.

About the Institutional Biosafety Committee

The WCG Institutional Biosafety Committee reviews applicable research involving recombinant or synthetic nucleic acid molecules and other work subject to NIH biosafety oversight. The committee evaluates whether research procedures, personnel, facilities and safety measures are appropriate for the proposed work.

NIH maintains public information about registered Institutional Biosafety Committees, including active rosters and key committee contact information. For current IBC registration information, visit the NIH Office of Science Policy.

View NIH guidance on public access to IBC meeting minutes.

For Additional Information

Compliance Contact
CARegulatorySubmissions@providence.org

Saint John’s Cancer Institute is committed to maintaining transparent access to required Institutional Biosafety Committee records while protecting confidential and appropriately redacted information.